Anthony Digiandomenico, Director at ENDRA Life Sciences Inc. (NDRA), bought 5,000 shares at $0.92 ($5K) on 2020-06-08, disclosed to the SEC on 2020-06-09.
Open-market purchase of $5k NDRA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| MDBH | BUY | 2025-02-14 | $8K | — | Filing → |
| MDBH | BUY | 2025-02-11 | $12K | — | Filing → |
| MDBH | BUY | 2025-02-06 | $4K | — | Filing → |